Federal Register Notices > Rules - 2005

Rules - 2005

NOTICE: This is an unofficial version. An official version of these publications may be obtained directly from the Government Printing Office (GPO).

• Implementation of the Anabolic Steroid Control Act of 2004 (December 16, 2005
• Proposed Rule 2005 - Controlled Substances and List I Chemical Registration and Reregistration Application Fees (November 16, 2005)
• Schedules of Controlled Substances: Placement of Embutramide Into Schedule III; Extension of Comment Period (August 29, 2005)
• Clarification of Existing Requirements Under the Controlled Substances Act for Prescribing Schedule II Controlled Substances (August 26, 2005)
• Reports by Registrants of Theft or Significant Loss of Controlled Substances (August 12, 2005)
• Schedules of Controlled Substances: Placement of Embutramide Into Schedule III (July 29, 2005)
• Schedules of Controlled Substances: Placement of Pregabalin Into Schedule V (July 28, 2005)

• Authority for Practitioners To Dispense or Prescribe Approved Narcotic Controlled Substances for Maintenance or Detoxification Treatment (June 23, 2005)

• Schedules of Controlled Substances: Placement of Pregabalin into Schedule V (May 13, 2005)

• Preventing the Accumulation of Surplus Controlled Substances at Long Term Care Facilities (May 13, 2005)

• Definition and Registration of Reverse Distributors (May 2, 2005)

• Schedules of Controlled Substances: Placement of Zopiclone Into Schedule IV (April 4, 2005)

• Electronic Orders for Controlled Substances (April 1, 2005)

  • Economic Impact Analysis of the Electronic Orders Rule (March 2005)

• Proposed Rule - Control of Sodium Permanganate as a List II Chemical (March 1, 2005)

• Proposed Rule - Schedules of Controlled Substances: Placement of Zopiclone Into Schedule IV (February 14, 2005)

• Chemical Mixtures; Temporary Waiver of Import/Export Requirements (February 4, 2005)

• Solicitation of Comments on Dispensing of Controlled Substances for the Treatment of Pain (January 18, 2005)

• Exemption of Chemical Mixtures; Correction (January 4, 2005)

• Recordkeeping and Reporting Requirements for Drug Products Containing Gamma-Hydroxybutyric Acid (GHB) (January 4, 2005)